| scholarly article | Q13442814 |
| P50 | author | Shunsuke Furuta | Q92598921 |
| P2093 | author name string | Hiroshi Nakajima | |
| Kei Ikeda | |||
| Norihiko Watanabe | |||
| Shin-Ichiro Kagami | |||
| Takao Sugiyama | |||
| Daisuke Kashiwakuma | |||
| Mieko Yamagata | |||
| Takahiro Kageyama | |||
| Takeshi Umibe | |||
| P2860 | cites work | Early Corticosteroids for Pneumocystis Pneumonia in Adults Without HIV Are Not Associated With Better Outcome | Q88502880 |
| Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer | Q33650105 | ||
| (1-->3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia. | Q35226026 | ||
| Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death | Q35793693 | ||
| Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature | Q36452691 | ||
| Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study | Q37690719 | ||
| Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients. | Q38065099 | ||
| Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented? | Q38794907 | ||
| Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case-control study | Q39214252 | ||
| Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia | Q39467565 | ||
| Pneumocystis jirovecci pneumonia in connective tissue diseases: Comparison with other immunocompromised patients | Q41362507 | ||
| Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection | Q42225047 | ||
| Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients | Q43757435 | ||
| Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. | Q44990606 | ||
| Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease | Q45240864 | ||
| Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals. | Q54287856 | ||
| Discontinuation of Secondary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy | Q57877986 | ||
| Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies | Q72811762 | ||
| Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy | Q79211608 | ||
| Pneumocystis pneumonia associated with infliximab in Japan | Q81542851 | ||
| Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases | Q85016620 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonia | Q12192 |
| P304 | page(s) | e0214324 | |
| P577 | publication date | 2019-03-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases | |
| P478 | volume | 14 |
Search more.